Delivery Order SPE2DB20D3103-SPE2DB25FN3A5

Award Date 4/3/25
Potential Completion Date 4/4/25
Potential Value $2.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $8,108.16 for the supply of 4562800712 TOPAMAX 200 MG TABLET 60S. The contract has an ultimate completion date of November 14, 2023 and is a Firm Fixed Price agreement. The award was made by the Defense Logistics Agency (DLA), a defense agency, and is not designated as a set-aside contract. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $39,867.80 firm fixed-price delivery order is for TOPAMAX 100 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of June 3, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award, valued at $35,879.46, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of TOPAMAX 50 MG TABLET 60S, a pharmaceutical product. The contract has a firm-fixed price pricing type and an ultimate completion date of May 14, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, valued at $7,397.54, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of TOPAMAX 100 MG TABLET 60S, a pharmaceutical product. It is not designated as a set-aside contract. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order (SPE2DX15D3020|SPE2DX25FPXZU) with a ceiling value of $1,989.14. The award is for the supply of TOPAMAX 100 mg tablets and was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a Defense agency. The contract is not designated with a set-aside, indicating open competition. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,035.18, is a Firm Fixed Price Delivery Order for the supply of TOPAMAX 100 MG TABLET 60S, a prescription medication. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of 4,567,221,590 units of the medication TOPAMAX 50 MG TABLET 60S. The $7,313.28 firm fixed price delivery order contract has a completion date of February 11, 2025 and is not designated as a set-aside. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The $1,732.05 Firm Fixed Price delivery order is for the supply of TOPAMAX 50 MG TABLET 60S, a prescription drug. The award does not have a set-aside designation. Amerisourcebergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,215.65, is for the delivery of TOPAMAX 50 MG TABLET 60S, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order, with a period of performance running through February 7, 2024. This award is not designated as a set-aside contract. Amerisourcebergen Drug...
This federal contract award, valued at $17,228.40, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a delivery order for the pharmaceutical product Topamax 200 mg tablets. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB25FN3A5
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $2,658.57 with a performance period through April 4, 2025. It is for the supply of TOPAMAX 200 MG TABLET 60S, a prescription medication.

Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation valued at $750,000 through May 2024, covering similar medical products and prescription drugs.

The contract award did not utilize any set-aside designations, indicating open competition. As a major federal vendor, Amerisourcebergen plays a critical role in supplying essential medical products and pharmaceuticals to various government agencies, particularly the DLA and military healthcare programs.

Generated 7/6/25, 12:45 AM